Tecan Group AG

Tecan Group reported first-half 2026 sales of 427.5 million Swiss francs, representing 3.4% growth in local currencies, and an adjusted EBITDA margin of 15.1%, while confirming its full-year guidance. Order entry rose 3.0% in local currencies, with a book-to-bill ratio above 1 in both the Life Sciences Business and Partnering Business segments. The adjusted EBITDA margin improved 10 basis points year-on-year despite 120 basis points of foreign-exchange headwinds and 50 basis points from tariffs, as underlying profitability improved 180 basis points. Adjusted earnings per share declined 1.5% to 2.62 francs, and operating cash flow fell to 17.0 million francs. The company also provided an update on its Rewired transformation program, including portfolio discipline measures, commercial expansion into India, and operational efficiency initiatives.

The South Korea automated liquid handling system market is projected to grow from $23.5 million in 2025 to $51.0 million by 2036, at a compound annual growth rate of 7.47%. The automated liquid handling system segment is expected to dominate by type, while liquid handling workstations lead by product. Drug discovery is the leading application, and pharmaceutical and biotechnology companies are the primary end users. Key players include Agilent Technologies, Revvity, Thermo Fisher Scientific, Danaher, and Tecan Group.

Tecan announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging the NVIDIA BioNeMo Agent Toolkit. The development, a milestone in the collaboration announced in March 2026, enables AI agents to access scientific AI capabilities directly within Introspect, helping laboratories move from reactive troubleshooting to proactive issue prevention. Early access is available for pharmaceutical, biotechnology, and clinical laboratory environments. The companies are also focusing on agentic guardrails for responsible AI deployment and plan to further develop AI-enabled platforms, including Physical AI for next-generation lab instrumentation.